Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix - a Rare Tumor
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 70
- 试验地点
- 1
- 主要终点
- Clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix
研究概览
简要总结
This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
详细描述
PRIMARY OBJECTIVE:
I. To perform a retrospective clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix at M D Anderson Cancer Center (MDACC) and to delineate the immunohistochemical and molecular profile of these cases.
OUTLINE:
Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with clear cell carcinoma of the cervix at MDACC
排除标准
- 未提供
研究组 & 干预措施
Observational (medical record review)
Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.
干预措施: Electronic Health Record Review (Other)
Observational (medical record review)
Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.
干预措施: Laboratory Biomarker Analysis (Other)
结局指标
主要结局
Clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix
时间窗: through study completion, an average of 1 year
次要结局
未报告次要终点